Endocrinology And Diabetes

Endocrinology is the branch of internal medicine that studies the glands that release hormones into the blood and the effects those hormones have on the rest of the body—growth, metabolism, reproduction, blood pressure, salt balance, and the body's response to stress.

13 frameworks, from 1500 to today · Internal Medicine · Medicine & Health

still a working view ended · each leads to its entry below

Overview

Endocrinology is the branch of internal medicine that studies the glands that release hormones into the blood and the effects those hormones have on the rest of the body—growth, metabolism, reproduction, blood pressure, salt balance, and the body's response to stress12. Diabetes mellitus, the condition in which blood glucose runs too high, sits at the centre of the field because it is both the most common endocrine disease and the one whose treatment has driven many of the field's technical advances. What is at stake is unusually concrete: an underactive thyroid can make a person slow, cold, and confused; an overactive adrenal gland can cause relentless high blood pressure; and poorly controlled diabetes can, over decades, blind, disable, and kill. The history of endocrinology is the history of how physicians learned that the body's organs talk to one another through chemical signals, and how they learned to measure those signals, replace them when missing, and block them when excessive.

Glands, Humours, and the First Chemical Signals

Before hormones were understood, the glands were mostly a mystery. Ancient and medieval medicine explained diseases as imbalances of four humours—blood, phlegm, yellow bile, black bile—and the glandular swellings of the neck (goitre) were attributed to "thickened" humours or to bad air and water. This humoral framework was not merely wrong; it organised observations for centuries and delayed the idea that a gland could manufacture a specific substance with a specific effect.

The first crack in the humoral picture came from anatomy. Seventeenth- and eighteenth-century anatomists dissected the thyroid, adrenals, pituitary, and gonads and described their structures, but their function remained obscure. A turning point was the recognition, during the nineteenth century, that removing a gland could produce disease. In 1849 the German physician Arnold Berthold showed that castrated roosters failed to develop normal combs and behaviour, and that transplanting testes back into the abdomen reversed the effect—an experiment implying that the testis releases a blood-borne substance. In the same period, surgeons observed that total thyroidectomy in animals and people caused weakness, swelling, and death, while the English physician Thomas Addison, in 1855, described the fatal syndrome—later Addison's disease—that follows destruction of the adrenal glands. These were not yet explanations, but they established that glands are essential organs whose removal has specific consequences.

The word "hormone," from the Greek for "to set in motion," was coined in 1905 by the physiologist Ernest Starling, who with William Bayliss had shown that the intestinal lining releases a chemical messenger, secretin, that travels in the blood to stimulate pancreatic secretion134. This was the decisive concept: a substance made in one organ, carried by blood, acting on another1. The demonstration that chemical messengers cross the body was the founding act of endocrinology as a discipline.

Diabetes Before Insulin: Diet and Starvation

Diabetes has been recognised since antiquity—the Greek physician Aretaeus described the melting away of the body into sweet urine. The sweetness was identified in the seventeenth century, and in the nineteenth the French clinician Apollinaire Bouchardat and later the German physicians established that sugar in the urine reflected a disturbance of carbohydrate metabolism, and that restricting food, especially sugar and starch, reduced it.

The first effective therapy was dietary5. Before any drug, the physicians of the late nineteenth and early twentieth centuries treated diabetes by underfeeding, and the most systematic version was the starvation therapy of Frederick Allen in the United States. Allen showed that severely restricting calories could prolong the lives of people with diabetes, but the price was chronic hunger and wasting, and children often died within a year or two. This was not a cure but a means of buying time5.

Insulin: The First Replacement Therapy

The discovery of insulin is the central turning point in the history of diabetes. In the early 1920s, at the University of Toronto, Frederick Banting and Charles Best, working under the physiologist John Macleod, prepared extracts of pancreatic tissue that lowered blood glucose in dogs167. A biochemist, James Collip, purified the extract sufficiently for use in people, and in 1922 a fourteen-year-old boy, Leonard Thompson, received it. Banting and Macleod received the Nobel Prize in 1923; Best and Collip did not, a decision long debated.

Insulin changed diabetes from a rapidly fatal disease into a chronic one. It also created a new problem: how much insulin, and when. Early insulins were short-acting extracts given several times a day, and patients and physicians learned through trial and error that the dose must be matched to food and activity. The purification and then the sequencing of insulin—its amino acid sequence was worked out in the 1950s by Frederick Sanger, and genetically engineered human insulin became available in the 1980s—made the drug safer and more predictable. Long-acting and rapid-acting analogues later allowed regimens that mimicked normal insulin secretion more closely.

Measuring Hormones: The Biochemistry of the 1930s and After

The next great advance was the ability to identify and measure hormones chemically. In the 1930s, the isolation of steroid hormones from the adrenal cortex and gonads—Edward Kendall and Philip Hench's work on cortisone, and the identification of sex steroids—showed that these hormones could be purified, dosed, and given as drugs. The synthesis of cortisone made possible the treatment of Addison's disease and, more broadly, the use of steroids as anti-inflammatory drugs, a development that reshaped many areas of medicine.

But until the 1960s, hormone measurement depended on bioassays—animal or tissue preparations that responded to a hormone and could only estimate it crudely. The revolution came with the radioimmunoassay developed by Rosalyn Yalow and Solomon Berson in the late 1950s89. The principle was elegant: a fixed amount of hormone is labelled with a radioactive isotope, and the unlabelled hormone in a patient's sample competes for binding to a specific antibody8. The more hormone in the sample, the less labelled hormone binds, and the amount can be calculated from the radioactive signal. Radioimmunoassay made it possible to measure hormones at concentrations of a billionth of a gram per millilitre, and it transformed endocrinology into a quantitative clinical science. Yalow received the Nobel Prize in 197789.

The Complications Paradigm: Diabetes Becomes a Disease of Slowly Damaging Glucose

For decades after insulin, the question was how tightly to control blood glucose. Physicians knew that high glucose over years damaged the eyes, kidneys, nerves, and blood vessels, but the evidence that tight control prevented these complications was weak. The turning point was the Diabetes Control and Complications Trial, published in 1993, which randomised people with type 1 diabetes to intensive versus conventional insulin therapy and showed that lower blood glucose substantially reduced retinopathy, nephropathy, and neuropathy. A parallel randomised trial in type 2 diabetes, the United Kingdom Prospective Diabetes Study, published in 1998, showed similar protection with intensive control.

This "glycaemic control" paradigm reshaped treatment targets, but it also revealed limits: tight control came at the cost of more serious hypoglycaemia, and in older or frail patients the benefit was less clear. The paradigm descended directly into modern practice, where glucose targets are individualised rather than universal.

Oral Drugs, Incretins, and the Biology of the Gut

Before the 1950s, type 2 diabetes had little drug therapy. The first oral agents were the sulfonylureas, introduced in the 1950s, which stimulate insulin release from the pancreas; they were later joined by metformin, a drug from the 1950s that reduces glucose production by the liver, and by other classes such as the thiazolidinediones. These drugs made type 2 diabetes manageable in primary care but were blunt tools with side effects.

A different turning point came from studying the gut. The observation that an oral glucose load triggers more insulin release than the same amount of glucose given intravenously led to the discovery of incretins—gut hormones, principally glucagon-like peptide-1 (GLP-1), that amplify insulin secretion after meals. Drugs that mimic GLP-1 or block its breakdown became available in the 2000s. Later trials showed that some of these drugs also reduce cardiovascular and kidney events, and that the sodium-glucose transporter inhibitors (SGLT2 inhibitors), a separate drug class developed earlier, protect the heart and kidney independently of glucose lowering. This "organ-protective" turn moved diabetes treatment beyond glucose numbers toward preventing the complications themselves.

Hormone Receptors and Molecular Endocrinology

The 1960s and 1970s brought the question of mechanism: how does a hormone act on a cell1? The answer came through receptor biology. In the 1960s, Earl Sutherland discovered cyclic AMP and the second-messenger principle—the idea that a hormone binding at the cell surface triggers a molecule inside the cell that carries the signal. Later work showed that steroid hormones act differently, entering the cell and binding to intracellular receptors that regulate gene expression directly3. The cloning of hormone receptors from the 1980s onward made it possible to understand diseases as receptor defects and to design drugs that block or activate specific receptors. Molecular endocrinology thus explained why a gland could be normal yet its hormone ineffective.

The other modern strand is genetics. The recognition that some endocrine diseases are inherited—including multiple endocrine neoplasia syndromes and various forms of congenital adrenal hyperplasia—led to genetic testing and counselling. More recently, the discovery of the leptin hormone in 1994 by Jeffrey Friedman and colleagues opened the biology of appetite and body-weight regulation, and human genetics has begun to identify common variants that influence diabetes risk.

Monitoring and Machines: The Present

Two technologies now define daily diabetes care. The first is continuous glucose monitoring: a small sensor worn under the skin measures glucose in the interstitial fluid every few minutes, allowing patients to see trends rather than isolated finger-stick values. The second is automated insulin delivery: a pump controlled by an algorithm that adjusts insulin based on sensor readings, sometimes called a closed-loop or "artificial pancreas."10 These systems, developed from the 2000s onward, have reduced hypoglycaemia and improved control in type 1 diabetes.

The present field is therefore a hybrid. It rests on classical glandular physiology and replacement therapy—thyroid hormone, cortisol, insulin—on the quantitative precision of radioimmunoassay and its modern analogues, on the complications paradigm of glucose control, and on a molecular pharmacology of receptors and gut hormones. Its open questions are real: how to prevent type 1 diabetes, how to reverse or prevent type 2 diabetes in the face of a global obesity epidemic, how to prevent hypoglycaemia in the most vulnerable, and how to use genetics and monitoring to individualise treatment rather than apply one target to all.

References

  1. Endocrinology (introduction, The endocrine system, History), Wikipedia
  2. Endocrine system, Wikipedia
  3. Nuclear receptor (History, introduction), Wikipedia
  4. Signal transduction (History), Wikipedia
  5. Diet in diabetes (History), Wikipedia
  6. History of diabetes, Wikipedia
  7. Frederick Banting, Wikipedia
  8. Radioimmunoassay (History, introduction), Wikipedia
  9. Immunoassay (History), Wikipedia
  10. Automated insulin delivery system, Wikipedia

The frameworks of Endocrinology And Diabetes

Each framework is a way of working the field has used: when it held, and the question it answers.

  1. 1500-1850
  2. 1849-1910
  3. 1870-1922
  4. 1905-1960

    Hormone

    How do organs signal one another?

    Fly to its tower in Nousfarer

  5. 1922-Present

    Insulin

    Can a missing hormone be replaced?

    Fly to its tower in Nousfarer

  6. 1930-1970
  7. 1955-Present

    Diabetes medication

    Can diabetes be treated with a pill?

    Fly to its tower in Nousfarer

  8. 1959-Present

    Radioimmunoassay

    How can tiny hormone amounts be measured?

    Fly to its tower in Nousfarer

  9. 1960-Present
  10. 1980-Present
  11. 1993-Present

    Glycaemic Control and Complications Paradigm

    Does tight glucose control prevent complications?

    Fly to its tower in Nousfarer

  12. 2005-Present
  13. 2005-Present

    Incretin and Organ-Protective Therapeutics

    Can drugs protect organs beyond lowering glucose?

    Fly to its tower in Nousfarer

How the ideas connect

Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.

Humoral and Glandular Anatomy Traditi…Experimental Glandular PhysiologyDietary and Starvation Therapy of Dia…HormoneInsulinSteroid Hormone Biochemistry and Gluc…Diabetes medicationRadioimmunoassayReceptor Biology and Second-Messenger…Molecular Genetics of Endocrine Disea…Glycaemic Control and Complications P…Continuous Glucose Monitoring and Aut…Incretin and Organ-Protective Therape…

Beyond the field

Where Endocrinology And Diabetes's ideas came from in other fields, and what they led to there: the strongest 12 of 64 links.

A city in Nousfarer: a red-carpeted stair climbing terraces to a crowned tower on an acropolis, more towers round it, forest and snowy mountains beyond.
A city in Nousfarer, the game played in the browser.

Endocrinology And Diabetes is a planet in Nousfarer

Its city has a tower for each of these 13 frameworks. Land, walk in, and climb one concept at a time.

Land on Endocrinology And Diabetes

Related fields

Fields its ideas are linked to

More in Internal Medicine

See where Endocrinology And Diabetes sits on the Map of Human Knowledge